{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:20:19Z","timestamp":1783160419508,"version":"3.54.6"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007103","name":"Semnan University","doi-asserted-by":"publisher","award":["226\/1404T14041086"],"award-info":[{"award-number":["226\/1404T14041086"]}],"id":[{"id":"10.13039\/501100007103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.vaccine.2026.128768","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:08:07Z","timestamp":1780315687000},"page":"128768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["XcpQ from Pseudomonas aeruginosa: A potential vaccine candidate with immunogenic properties in zebrafish"],"prefix":"10.1016","volume":"87","author":[{"given":"Aryan","family":"Nouhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamsozoha","family":"Abolmaali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakiba","family":"Darvish Alipour Astaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128768_bb0005","unstructured":"Abrignani S, Ahmed SS, Amanna IJ, Anderson TA, Arlett PR, Atkinson WL, et al. Contributors. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM, editors. Plotkin's Vaccines (Seventh Edition) [Internet]. Elsevier; 2018. p. xii\u2013xix. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B978032.3357616000924."},{"key":"10.1016\/j.vaccine.2026.128768_bb0010","article-title":"Pseudomonas aeruginosa: recent advances in vaccine development","volume":"10","author":"Killough","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128768_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/cells12010199","article-title":"Pseudomonas aeruginosa: infections, animal modeling, and therapeutics","volume":"12","author":"Wood","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.vaccine.2026.128768_bb0020","article-title":"Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.vaccine.2026.128768_bb0025","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s40265-021-01635-6","article-title":"The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update","volume":"81","author":"Reynolds","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2026.128768_bb0030","article-title":"Antibiotic action and resistance: updated review of mechanisms, spread, influencing factors, and alternative approaches for combating resistance","volume":"14","author":"Halawa","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.vaccine.2026.128768_bb0035","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1128\/JB.01563-14","article-title":"Txc, a new type II secretion system of Pseudomonas aeruginosa strain PA7, is regulated by the TtsS\/TtsR two-component system and directs specific secretion of the CbpE chitin-binding protein","volume":"196","author":"Cadoret","year":"2014","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2026.128768_bb0040","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1098\/rstb.2011.0204","article-title":"On the path to uncover the bacterial type II secretion system","volume":"367","author":"Douzi","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.vaccine.2026.128768_bb0045","doi-asserted-by":"crossref","first-page":"40792","DOI":"10.1074\/jbc.M111.294843","article-title":"Deciphering the Xcp Pseudomonas aeruginosa type II secretion machinery through multiple interactions with substrates","volume":"286","author":"Douzi","year":"2011","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128768_bb0050","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1006\/jmbi.1999.3340","article-title":"The C-terminal domain of the Pseudomonas secretin XcpQ forms oligomeric rings with pore activity","volume":"294","author":"Brok","year":"1999","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2026.128768_bb0055","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/mmi.14664","article-title":"The structure and mechanism of the bacterial type II secretion system","volume":"115","author":"Naskar","year":"2021","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2026.128768_bb0060","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1046\/j.1365-2958.1998.00888.x","article-title":"Identification of an additional member of the secretin superfamily of proteins in Pseudomonas aeruginosa that is able to function in type II protein secretion","volume":"28","author":"Martinez","year":"1998","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2026.128768_bb0065","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3389\/fimmu.2020.01362","article-title":"Application of outer membrane protein-based vaccines against major bacterial fish pathogens in India","volume":"11","author":"Maiti","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128768_bb0070","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/infdis\/jir045","article-title":"Type II secretion system of Pseudomonas aeruginosa: in vivo evidence of a significant role in death due to lung infection","volume":"203","author":"Jyot","year":"2011","journal-title":"J Infect Dis"},{"issue":"W1","key":"10.1016\/j.vaccine.2026.128768_bb0075","doi-asserted-by":"crossref","first-page":"W287","DOI":"10.1093\/nar\/gkae328","article-title":"Deep learning for the PSIPRED protein analysis workbench","volume":"52","author":"Buchan","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"10.1016\/j.vaccine.2026.128768_bb0080","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/bioinformatics\/btq249","article-title":"PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes","volume":"26","author":"Yu","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2026.128768_bb0085","article-title":"Genomes PtptwahMmAtc","author":"Krogh","year":"2001","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/j.vaccine.2026.128768_bb0090","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1110\/ps.03479604","article-title":"Predicting subcellular localization of proteins for gram-negative bacteria by support vector machines based on n-peptide compositions","volume":"13","author":"Yu","year":"2004","journal-title":"Protein Sci"},{"key":"10.1016\/j.vaccine.2026.128768_bb0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data Bank (2000)","volume":"28","author":"Berman","year":"2026","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2026.128768_bb0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2105-9-62","article-title":"VirulentPred: a SVM based prediction method for virulent proteins in bacterial pathogens","volume":"9","author":"Garg","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.vaccine.2026.128768_bb0105","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1093\/nar\/gkg563","article-title":"Analysis Etpsfi-dpka","volume":"31","author":"Gasteiger","year":"2003","journal-title":"NAR"},{"key":"10.1016\/j.vaccine.2026.128768_bb0110","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1471-2105-10-421","article-title":"BLAST+: architecture and applications","volume":"10","author":"Camacho","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.vaccine.2026.128768_bb0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1875035400801010022","article-title":"Bioinformatic approach for identifying parasite and fungal candidate subunit vaccines","volume":"1","author":"Doytchinova","year":"2008","journal-title":"Open Vaccines Journal"},{"key":"10.1016\/j.vaccine.2026.128768_bb0120","doi-asserted-by":"crossref","unstructured":"Vita R BN, Marrama D; IEDB Curation Team Members; Duesing S, Bennett J, Greenbaum J, De Almeida Mendes M, Mahita J, Wheeler DK, Cantrell JR, Overton JA, Natale DA, Sette A, Peters B. The Immune Epitope Database (IEDB): 2024 update. Nucleic Acids Res. 2025 Jan 6;53(D1):D436-D443. doi:https:\/\/doi.org\/10.1093\/nar\/gkae1092. PMID: 39558162; PMCID: PMC11701597. doi:https:\/\/doi.org\/10.1093\/nar\/gkae1092.","DOI":"10.1093\/nar\/gkae1092"},{"key":"10.1016\/j.vaccine.2026.128768_bb0125","doi-asserted-by":"crossref","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v.2 - a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J Mol Model"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128768_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS One"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2026.128768_bb0135","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1107\/S2059798322002741","article-title":"Elucidation of protein function using computational docking and hotspot analysis by ClusPro and FTMap","volume":"78","author":"Jones","year":"2022","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1016\/j.vaccine.2026.128768_bb0140","series-title":"Molecular cloning: A laboratory manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.vaccine.2026.128768_bb0145","series-title":"In Vitro toxicity testing protocols. Methods in molecular biology\u2122","article-title":"MTT Assays","volume":"43","author":"Supino","year":"1995"},{"key":"10.1016\/j.vaccine.2026.128768_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106473","article-title":"Anti-OmpA antibodies as potential inhibitors of Acinetobacter baumannii biofilm formation, adherence to, and proliferation in A549 human alveolar epithelial cells","volume":"186","author":"Barati","year":"2024","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2026.128768_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180666","article-title":"The KP1_4563 gene is regulated by the cAMP receptor protein and controls type 3 fimbrial function in Klebsiella pneumoniae NTUH-K2044","volume":"12","author":"Luo","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128768_bb0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/zeb.2012.0862","article-title":"A novel, reliable method for repeated blood collection from aquarium fish","volume":"10","author":"Zang","year":"2013","journal-title":"Zebrafish"},{"key":"10.1016\/j.vaccine.2026.128768_bb0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s43141-021-00199-y","article-title":"Screening and characterization of hypothetical proteins of plasmodium falciparum as novel vaccine candidates in the fight against malaria using reverse vaccinology","volume":"19","author":"Aguttu","year":"2021","journal-title":"J Genet Eng Biotechnol"},{"key":"10.1016\/j.vaccine.2026.128768_bb0170","doi-asserted-by":"crossref","first-page":"17199","DOI":"10.1038\/s41598-021-96233-7","article-title":"Homology between SARS CoV-2 and human proteins","volume":"11","author":"Khavinson","year":"2021","journal-title":"Sci Rep"},{"issue":"6522","key":"10.1016\/j.vaccine.2026.128768_bb0175","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.abf0357","article-title":"Ensuring vaccine safety","volume":"370","author":"Knipe","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.128768_bb0180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1208\/s12248-008-9027-6","article-title":"In vitro studies are sometimes better than conventional human pharmacokinetic in vivo studies in assessing bioequivalence of immediate-release solid oral dosage forms","volume":"10","author":"Polli","year":"2008","journal-title":"AAPS J"},{"key":"10.1016\/j.vaccine.2026.128768_bb0185","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1007\/s00204-024-03854-8","article-title":"A review of the scientific literature on experimental toxicity studies of COVID-19 vaccines, with special attention to publications in toxicology journals","volume":"98","author":"Domingo","year":"2024","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.vaccine.2026.128768_bb0190","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4161\/hv.26565","article-title":"A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF\/I vaccine (IC43) in healthy volunteers","volume":"10","author":"Westritschnig","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128768_bb0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-immunol-030409-101311","article-title":"The sterile inflammatory response","volume":"28","author":"Rock","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.128768_bb0200","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.128768_bb0205","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/14760584.2024.2345685","article-title":"The zebrafish as a potential model for vaccine and adjuvant development","volume":"23","author":"Hotez","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.128768_bb0210","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/1462-2920.16440","article-title":"Using model systems to unravel host-Pseudomonas aeruginosa interactions","volume":"25","author":"Grandy","year":"2023","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.vaccine.2026.128768_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01181","article-title":"Current challenges in vaccinology","volume":"11","author":"Kennedy","year":"2020","journal-title":"Front Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:13:22Z","timestamp":1783160002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26005773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":43,"alternative-id":["S0264410X26005773"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128768","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"XcpQ from Pseudomonas aeruginosa: A potential vaccine candidate with immunogenic properties in zebrafish","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128768"}}